Actionable news
All posts from Actionable news
Actionable news in HOLX: Hologic, Inc.,

Highlighted Post-Market Laggard: Hologic (HOLX)

Trade-Ideas LLC identified Hologic ( HOLX) as a post-market laggard candidate. In addition to specific proprietary factors, Trade-Ideas identified Hologic as such a stock due to the following factors:

  • HOLX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $98.0 million.
  • HOLX is down 3.8% today from today's close.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in HOLX with the Ticky from Trade-Ideas. See the FREE profile for HOLX NOW at Trade-Ideas More details on HOLX: Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States and internationally. The company operates in four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. HOLX has a PE ratio of 84. Currently there are 9 analysts that rate Hologic a buy, no analysts rate it a sell, and 9 rate it a hold. The average volume for Hologic has been 2.9 million shares per day over the past 30 days. Hologic has a market cap of $11.2 billion and is part of the health...